In addition, IFN-γ and TLR9 can induce the expression of T-bet and CXCR3 in MS patients to further enhance CXCR3-mediated recruitment to lesions and to trigger local lesions in MS patients. The gene discussed is TLR9; the disease is myeloid sarcoma.